[Multimodal therapy in colon carcinoma].
Seufferlein
T
T
Abteilung Innere Medizin I, Universitätsklinikum Ulm. thomas.seufferlein@medizin.uni-ulm.de
Lutz
M P
MP
Adler
G
G
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000556:secondary / Q000601:surgery; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D011379:Prognosis
D000970:Antineoplastic Agents